Application of Riyad R. Irani and Kurt Moedritzer

427 F.2d 806, 57 C.C.P.A. 1109
CourtCourt of Customs and Patent Appeals
DecidedJune 11, 1970
DocketPatent Appeal 8298
StatusPublished
Cited by1 cases

This text of 427 F.2d 806 (Application of Riyad R. Irani and Kurt Moedritzer) is published on Counsel Stack Legal Research, covering Court of Customs and Patent Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Application of Riyad R. Irani and Kurt Moedritzer, 427 F.2d 806, 57 C.C.P.A. 1109 (ccpa 1970).

Opinion

RICH, Chief Judge.

This appeal is from a decision of the Patent Office Board of Appeals affirming the rejection of claim 1 of application serial No. 420,795, filed December 23, 1964, entitled “Chemical Compound,” stated to be a continuation-in-part of application serial No. 152,048, filed November 13, 1961. We reverse.

The appealed claim, the only claim in the application, reads:

1. Crystalline anhydrous amino tri (methylenephosphonic acid). [Emphasis added.]

This compound, which is sometimes hereinafter referred to as “ATMP,” has the structural formula:

*807 The subscript “3” indicates that there are three methylenephosphonic acid radicals attached to the nitrogen atom. The application discloses that this compound is useful as “a sequestering agent, defloeculating agent, detergent builder and the like.”

The references relied on are:

Kosolapoff, Organophosphorus Compounds (1950), pp. 143, 155, and 156.
Petrov, Chemical Abstracts, Vol. 54 (1960), col. 260
Pikl 2,328,358 Aug. 31, 1943
Bersworth 2,841,611 July 1, 1958
Irani 3,234.124 Feb. 8. 1966
(filed Oct. 18, 1962)

Petrov, the primary reference, discloses amino tri (methylenephosphonic) acid, a specific form of which is being claimed here. This reference, which is acknowledged in appellant’s specification, also sets forth a procedure for preparing ATMP and describes the product as a “glassy solid" (emphasis added). “Glassy” we take to mean like glass and glasses is an amorphous, i. e., now-crystalline, material.

The Kosolapoff and Bersworth refererences are relied on “as showing crystalline amino phosphonic acids,” and Pikl and Bersworth as showing “the use of amino substituted phosphonic acids as softeners, sequesterants or chelating agents * * Irani, which is not prior art with respect to appellant’s application, is cited as showing that “little modification of the Petrov * * * process will produce a crystalline material * *

Claim 1 was rejected by the examiner “as obvious under 35 U.S.C. 103 over Petrov et al who disclose amino-tri (methlyenephosphonic acid) which is considered to suggest the instantly claimed material * * Notwithstanding that the examiner, and the board, referred only to Petrov in stating this rejection, it is abundantly clear that significant reliance was and is placed on the Kosolapoff, Pikl, and Bersworth references. Appellants, however, do not now complain of this and we will therefore consider the rejection as applied rather than as stated.

The examiner was of the opinion that one skilled in the art knowing of Petrov’s “glassy solid” form of ATMP would be motivated to attempt the preparation of crystalline anhydrous ATMP by the knowledge that some amino phosphonic acids exist in crystalline form (Kosolapoff and Bersworth) and that some amino phosphonic acids are useful as softeners, sequesterants, or chelating agents (Pikl and Bersworth).

Purporting to place less reliance on the secondary references than did the examiner, the board stated:

Despite the fact that the Examiner has referred to three additional patents and one additional publication, the essential point is the obviousness of the “crystalline anhydrous” form of the claimed compound in view of the Petrov et al. disclosure of “a glassy solid” form of the same compound. As we view the comparative properties in Table 1 * * * of appellants’ specification, * * * the general indication is that the Petrov et al. material is an impure form of amino tri (methylenephosphonic acid).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bristol-Myers Co. v. U.S. Intern. Trade Com'n
892 F.2d 1050 (Federal Circuit, 1989)

Cite This Page — Counsel Stack

Bluebook (online)
427 F.2d 806, 57 C.C.P.A. 1109, Counsel Stack Legal Research, https://law.counselstack.com/opinion/application-of-riyad-r-irani-and-kurt-moedritzer-ccpa-1970.